Tim Smith

During a recent interview regarding ReOpen1 and ReOpen2 trials, Dr. Mahmoud described a new treatment device for chronic rhinosinusitis patients.

The recent GUIDE study examined the efficacy of guselkumab for moderate-to-severe plaque psoriasis, finding it consistent with previous trials.

Recent phase 3 trial results suggest positive effects and faster onset using CAL/BDP cream for adult plaque psoriasis.

A discussion regarding the use of plaque psoriasis treatments such as apremilast, ixekizumab, and methotrexate.

When compared to an intervention system guided by a therapist, a newly-designed self care system for atopic dermatitis patients may be as helpful.

Dr. Chopra elaborated on his Pri-Med Midwest 2022 presentation regarding the future of advances in medicine, specifically highlighting artificial intelligence, gut microbiome research, and gene editing.

Dr. Chopra described several key points of his Pri-Med Midwest presentation regarding the future of advances in medicine, including artificial intelligence, gut bacteria, and CRISPR technology.

A highlighted description of some key takeaways from presentations at Pri-Med Midwest 2022, including such topics as infectious disease, monkeypox, colorectal cancer, psoriasis, and COVID-19.

An interview with Dr. Anwuri regarding her Pri-Med Midwest presentation on treating adult plaque psoriasis.

In an interview during Pri-Med Midwest, Dr. Kushner spoke about the benefits of treating obesity and diabetes synchronously.

A discussion with Dr. Vega regarding colorectal cancer screenings, aspirin use recommendations, and the current state of healthcare.

An interview with Dr. Vega regarding atrial fibrillation and clinical manifestations for ADPKD.

A discussion with Dr. Angarone regarding his presentation at Pri-Med Midwest, exploring the topic of treating infectious disease in developing countries.

A discussion regarding highlights from Dr. Charles Vega’s presentation on common urgent care presentations and concerns regarding acute pain.

Dr. Angarone highlighted several key takeaways from his presentation at Pri-Med Midwest.

A discussion regarding highlights from Dr. Michael Angarone’s presentation on emerging infectious diseases.

Research suggests disparities between racial and ethnic groups exist among patients with Alzheimer’s disease and related dementias.

A recent study confirmed the safety of tralokinumab with regard to COVID-19 and related vaccinations.

Researchers evaluated the use of IVIG for patients with the rare autoimmune disorder dermatomyositis.

A recent cohort study of 20 emergency departments assessed allergic contact dermatitis cases.

Children at risk for developing asthma may see benefits from a new screening tool developed to detect symptoms in children age 3 and up.

A research team described data regarding the potential of escalating adalimumab doses for certain patients with psoriasis.

A recent study found that worsened visual acuity and depression were associated with neurobiological changes visible through MRI scans.

A combination therapy approach may be useful for psoriasis treatment, though an 8-week regimen may not be long enough.

A discussion with Dr. Lal on the successful trials and recent approval of dupilumab as a treatment for skin inflammation.

Data indicates a greater number of physicians is a better predictor of melanoma diagnoses than UV radiation rates.

A study finds delayed puberty, a comorbidity of epidermolysis bullosa, may affect skeletal health.

The FDA recently approved a drug treatment for prurigo nodularis, studied across over 60 clinical trials.

A review examined the ways in which costs can be reduced for patients with varying types of atopic dermatitis.

A discussion on the positive outcomes of acupuncture for Parkinson’s patients struggling with the effects of anxiety.